Sol-Gel Technologies Operating Income

As of the most recent data (June 2026), SLGL shows a operating income of $-36M. That compares with $13M in the prior-year period — down 368.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SLGL's operating income is now $-36M (was $13M) — a 368.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Sol-Gel Technologies is outperforming or lagging.

Tracking SLGL's operating income over time shows whether Sol-Gel Technologies is scaling, shrinking, or reshaping that part of the business. The current reading is $-36M That compares with $13M in the prior-year period — down 368.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has Sol-Gel Technologies's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-36M) with ownership activity and broader fundamentals.

Sol-Gel Technologies's operating income is $-36M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.